Boesjes CM, Van der Gang LF, Zuithoff NPA, Bakker DS, et al. Effectiveness of Upadacitinib in Patients with Atopic Dermatitis including those with Inadequate Response to Dupilumab and/or Baricitinib: Results from the BioDay Registry. Acta Derm Venereol 2023;103:adv00872.
PMID: 36794894